Growth Metrics

Cytosorbents (CTSO) Gross Profit Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 6.52%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.76%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 4.41%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 12.59%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 15.74%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 6.30%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 27.39%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -1.74%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 8.72%
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn -1.24%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.24%
Dec 31, 2025 8.78%
Sep 30, 2025 26.83%
Jun 30, 2025 4.78%
Mar 31, 2025 -9.70%
Dec 31, 2024 17.77%
Sep 30, 2024 -6.26%
Jun 30, 2024 8.05%
Mar 31, 2024 26.00%
Dec 31, 2023 -7.74%
Sep 30, 2023 55.00%
Jun 30, 2023 21.71%
Mar 31, 2023 -14.94%
Dec 31, 2022 -24.84%
Sep 30, 2022 -50.43%
Jun 30, 2022 -46.91%
Mar 31, 2022 -18.27%
Dec 31, 2021 -18.76%
Sep 30, 2021 -4.69%
Jun 30, 2021 42.30%
Mar 31, 2021 24.12%
Dec 31, 2020 76.71%
Sep 30, 2020 74.06%
Jun 30, 2020 48.82%
Mar 31, 2020 83.10%
Dec 31, 2019 33.47%
Sep 30, 2019 19.20%
Jun 30, 2019 10.80%
Mar 31, 2019 2.86%
Dec 31, 2018 18.21%
Sep 30, 2018 59.93%
Jun 30, 2018 90.46%
Mar 31, 2018 80.58%
Dec 31, 2017 89.29%
Sep 30, 2017 59.37%
Jun 30, 2017 54.49%
Mar 31, 2017 87.65%
Dec 31, 2016 86.65%
Sep 30, 2016 105.43%
Jun 30, 2016 170.62%
Mar 31, 2016 136.67%
Dec 31, 2015 75.84%
Sep 30, 2015 2.67%
Jun 30, 2015 39.05%
Mar 31, 2015 4.74%
Dec 31, 2014 1,218.47%
Sep 30, 2014 163.95%
Jun 30, 2014 289.98%
Mar 31, 2014 239.19%
Dec 31, 2013 -92.44%
Sep 30, 2013 -43.89%
Jun 30, 2013 25.99%
Mar 31, 2013 3,360.07%
Dec 31, 2012 2,145.76%